A new study from experts at the University of Exeter has found that a widely used test for prostate cancer may leave black men at increased risk of overdiagnosis.
Enara Bio’s $32.5M Series B to support lead dark antigen program for GI cancers
Enara Bio has snagged $32.5 million in a Series B fundraise, backed in part by Pfizer’s venture arm, to help develop a preclinical pipeline of